Boston Scientific accounts are for healthcare professionals only.
VITALIO™ Pacemaker Pacemaker
Reimbursement
Configure or select a product to continue to order
- Overview
Overview
Respiration-based Pacing
VITALIO pacemakers offer RightRate, which combines an MV sensor with enhanced programming. The MV sensor is the only sensor clinically proven to restore chronotropic competence1. RightRate incorporates programming improvements such as automatic sensor calibration, a simplified user interface, and a sensor replay to make patient optimization easier.
RF Wireless Enabled
VITALIO features wireless telemetry to make follow-ups easer and offers intuitive ease of use with Boston Scientific's universal user interface.
Management of Unnecessary RV Pacing
VITALIO provides options to manage RV pacing in patients with varying degrees of conduction block. VITALIO features RYTHMIQ™ which is designed to minimize unnecessary pacing without clinically significant pauses. RYTHMIQ operates in an atrial pacing mode during times of normal conduction, switching to a dual-chamber mode when a conduction block is detected. VITALIO also includes AV Search+, which is also designed to reduce unnecessary RV pacing through the extension of the AV delay.
Fully Automatic
The VITALIO pacemaker incorporates PaceSafe™ RV automatic capture and RA automatic threshold to automatically adjust pacing thresholds. These algorithms can increase projected longevity, adjust fluctuating thresholds, and are simple to use with single-button programming.
Respiratory Rate Trend
VITALIO features Respiratory Rate Trend, which uses a transthoracic impedance signal to measure respiration, and tracks daily maximum, median, and minimum respiration rates.
References
1. Chronotropic competence is defined by the Model of the Cardiac Chronotropic Response to Exercise. Wilkoff B, Corey J, Blackburn G. A mathematical model of the cardiac chronotropic response to exercise. Journal of Electrophysiology. 1989;3:176–180. Refer to the Physician’s System Guide for more information on adaptive-rate therapy. Additional clinical performance was assessed using INSIGNIA® Ultra clinical data with the AutoLifestyle® feature programmed On. Boston Scientific. Data on file. www.bostonscientific.com/ifu